Suppr超能文献

新冠病毒肺炎插管ARDS患者输注康复期血浆后的肺生理改变

Alteration of Lung Physiology with the Administration of Convalescent Plasma in ARDS Patients Intubated with COVID-19 Pneumonia.

作者信息

Presti Thomas, Nathanson Brian H, Schlecht Hans P, Steingrub Jay S, DiNino Ernest K

机构信息

Department of Pulmonary and Critical Care Medicine University of Massachusetts Chan Medical School-Baystate, Springfield, MA, United States.

OptiStatim, LLC, Longmeadow, MA 01106, United States.

出版信息

Brown J Hosp Med. 2022 Nov 1;2(1):39621. doi: 10.56305/001c.39621. eCollection 2023.

Abstract

BACKGROUND

It remains unknown to what degree lung physiology is altered by administration of convalescent plasma in patients intubated with ARDS due to COVID-19 pneumonia. Although no longer clinically used as treatment for COVID-19, convalescent plasma therapy could be deployed again should new virus threats emerge in the future.

AIM

To evaluate changes in ventilator physiologic variables in response to convalescent plasma transfusion using a retrospective, observational, case control study of intubated patients with COVID-19 pneumonia.

METHODS

Patients who were receiving mechanical ventilation due to COVID-19 at the time of administration of convalescent plasma therapy (CPT) were matched to control patients who did not receive convalescent plasma. Ventilatory data such as compliance, positive end-expiratory pressure (PEEP), FiO administered, PaO/FiO ratio, and tidal volume were collected pre and post administration. Panel-level random-effects linear regression models were used to assess the mean difference and interactions between CPT and cases vs controls over time.

RESULTS

12 patients received CPT while intubated and were matched to 35 intubated control patients who did not receive CPT. In total, 857 separate measurements of static compliance were obtained over time. No significant difference in static compliance was seen after CPT. In cases, adjusted mean static compliance was 30.8 (95% CI (23.3, 38.4))mL/cm HO before CPT and 28.2 (95% CI (20.7,35.6)) mL/cm HO afterwards. Controls adjusted mean static compliance was 33.9 (95% CI (29.5, 38.4)) mL/cm HO before versus 32.2 (95% CI (27.9, 36.5)) mL/cm HO afterwards. Variables that had small but statistically significant differences pre vs post CPT among cases and controls were systolic and diastolic blood pressure, FiO, heart rate, applied PEEP, and respiratory rate.

CONCLUSION

While some statistically significant physiologic effects were seen with CPT in mechanically ventilated patients, these were deemed to be small and clinically insignificant. This is consistent with prior research on less acutely ill COVID-19 patients.

摘要

背景

对于因新型冠状病毒肺炎(COVID-19)导致急性呼吸窘迫综合征(ARDS)而插管的患者,给予恢复期血浆后肺生理功能改变的程度尚不清楚。尽管恢复期血浆疗法不再作为COVID-19的临床治疗方法,但如果未来出现新的病毒威胁,可能会再次使用。

目的

通过对插管的COVID-19肺炎患者进行回顾性观察病例对照研究,评估恢复期血浆输注后呼吸机生理变量的变化。

方法

在给予恢复期血浆治疗(CPT)时因COVID-19接受机械通气的患者与未接受恢复期血浆的对照患者进行匹配。在给药前后收集通气数据,如顺应性、呼气末正压(PEEP)、给予的FiO₂、PaO₂/FiO₂比值和潮气量。使用面板水平随机效应线性回归模型评估CPT与病例组和对照组随时间的平均差异及相互作用。

结果

12例患者在插管时接受了CPT,并与35例未接受CPT的插管对照患者进行匹配。随着时间的推移,共获得了857次静态顺应性的单独测量值。CPT后静态顺应性未见显著差异。病例组中,CPT前调整后的平均静态顺应性为30.8(95%CI(23.3,38.4))mL/cmH₂O,之后为28.2(95%CI(20.7,35.6))mL/cmH₂O。对照组调整后的平均静态顺应性在CPT前为33.9(95%CI(29.5,38.4))mL/cmH₂O,之后为32.2(95%CI(27.9,36.5))mL/cmH₂O。病例组和对照组在CPT前后有小但具有统计学意义差异的变量是收缩压和舒张压、FiO₂、心率、应用的PEEP和呼吸频率。

结论

虽然在机械通气患者中CPT观察到了一些具有统计学意义的生理效应,但这些效应被认为较小且临床意义不大。这与先前对病情较轻的COVID-19患者的研究一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5104/11878892/31d5f8ede199/bhm_2023_2_1_39621_102973.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验